Prescribey LLC
1309 Coffeen Avenue, STE 1200
Sheridan, Wyoming 82801
Phone: 1-833-277-3278
Email: support@prescribey.com
By proceeding with our services, you understand and agree that:
By using our services, you confirm the following:
Prescribey LLC complies with HIPAA and applicable privacy laws. Your health data is protected and used only for purposes of treatment, care coordination, and service administration.
By signing electronically or proceeding with our service, you voluntarily consent to receive care via telehealth from providers working with or through Prescribey LLC.
You acknowledge that all your questions about this consent have been answered to your satisfaction and that you may withdraw consent at any time by discontinuing use of the services.
Effective Date: April 30, 2025
Home Privacy Statement Medical Consent Privacy Practices Patient Rights Privacy Policy Terms & conditions
- Medical Disclaimer and Program Details –
Prescribey.com
Please note: Completing an online assessment on
Prescribey.com does not create a
doctor–patient relationship. Prescribey works with a network of
U.S.-licensed providers through OpenLoop Health, who follow strict
medical protocols to ensure patient safety. These providers utilize
clinical exclusion criteria to determine eligibility for GLP-1
therapy. Your responses to the Prescribey health assessment will be
reviewed by a licensed clinician after checkout to assess medical
suitability. All prescription decisions are made solely at the
discretion of the licensed provider.
Claims and outcomes featured on
Prescribey.com are based on
self-reported results from individuals using compounded GLP-1
medications under medical supervision. Weight loss results were
reported via patient intake forms and follow-up check-ins every 3–4
weeks. Results will vary based on individual adherence to the
prescribed protocol, diet, exercise, and provider recommendations.
- Important Notes on Compounded Medications:
Prescribey partners with certified U.S. compounding pharmacies that
operate in FDA-registered and highly regulated facilities. However,
compounded GLP-1 medications are not FDA-approved, and have not been
reviewed by the FDA for safety, efficacy, or quality. The decision to
prescribe compounded medications is based on the provider’s medical
judgment following a telehealth consultation and evaluation of your
medical history.
We encourage all patients to consult with a licensed healthcare
provider about the risks and benefits of compounded medication.
Medications may vary in appearance from those shown on the website.
Prescribey does not manufacture medications.
- Pharmacy Partnerships:
Prescribey works with multiple certified U.S. pharmacy partners to
ensure quality, reliability, and timely service. Our team maintains
regular communication with partner pharmacies to monitor product
availability, testing protocols, and shipping timelines.
- Results & FDA-Approved Treatments:
Weight loss results vary. Patients in our program who followed a
reduced-calorie diet and daily exercise routine reported weight loss
of 1–2 pounds per week after 4 weeks. Not all patients will experience
the same results. Inches lost (waist, hips, arms, chest, thighs) are
based on individual metrics and adherence to the program. Medication
prescriptions are not guaranteed and are subject to clinical
evaluation and provider discretion.
Wegovy® is FDA-approved for weight management in certain patients.
Ozempic® is FDA-approved for the treatment of type 2 diabetes and may
be prescribed off-label for weight loss. Medication costs are included
in the Prescribey program. All trademarks (Wegovy®, Ozempic®, etc.)
remain the property of their respective owners.
- Medical services provided by OpenLoop-affiliated provider groups
- © Prescribey LLC. All rights reserved